Evaluating TENEX for hip pain relief
Official title: Evaluation of Percutaneous Tenotomy of the Gluteus Medius and Iliotibial Band for Greater Trochanteric Pain Syndrome (GTPS): A Randomized Clinical Trial
Run by Montefiore Medical Center · NCT05710627 · Data updated 2026-11-12
This study is testing if a special ultrasound-guided procedure called TENEX can help people with chronic hip pain feel better and move easier when other treatments haven't worked.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 90 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Montefiore Medical Center Academic / other |
| Locations | 1 site (The Bronx, New York) |
| Status | Recruiting |
| Started | March 11, 2025 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT05710627 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-90 with confirmed GTPS who have not improved after at least six months of conservative medical management.
✕Probably not a fit
Patients with significant mobility restrictions, those who are pregnant, or individuals who have had previous surgery on the affected tendons may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of an ultrasound-guided procedure called TENEX for treating chronic hip pain caused by Greater Trochanteric Pain Syndrome (GTPS). The procedure involves a partial release of the gluteus medius and minimus tendons, as well as the Iliotibial band, in patients who have not responded to conservative treatments for at least six months. The goal is to reduce pain, improve mobility, and decrease the need for medication, thereby enhancing patients' ability to perform daily activities. The study will compare outcomes between those receiving the TENEX treatment and a control group.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve mobility for patients suffering from GTPS.
How similar studies have gone: Previous studies have shown promising results with similar approaches, indicating a potential for significant improvement in pain management for GTPS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18-90 * People with GTPS of all different levels and etiologies confirmed with MRI or CT scan * Ability to give informed consent forms independently * Failed conservative medical treatment for at least 6 months Exclusion Criteria: * Significant mobility restrictions; people using wheelchairs * Pregnancy * Previous surgery to the GMed or ITB
Where it's running
-
Montefiore Medical Center
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Sayed E. Wahezi, MD — Montefiore Medical Center
- Study coordinator: Tahereh Naeimi, MD
- Email: tnaeimi@montefiore.org
- Phone: 3479778678
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-Intensity Laser Therapy for Greater Trochanteric Pain Syndrome
This trial tests whether high-intensity laser therapy can reduce pain and improve function for adults with GTPS compared with a sham treatment.
-
ReneuRx for lateral hip pain: a treatment option for people with GTPS
This study tests whether the ReneuRx device can relieve moderate to severe lateral hip pain in adults compared with a corticosteroid injection.
-
ESWT versus conventional physical therapy for Greater Trochanteric Pain Syndrome
This trial will try Extracorporeal Shockwave Therapy (ESWT) against usual physical therapy to see which reduces pain and improves function in adults with Greater Trochanteric Pain Syndrome.
-
Exercise and education program for lateral hip pain
This study is testing whether a special exercise program and education can help people with lateral hip pain feel better after 12 weeks of treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.